Education
About Us
Working with TipRanks
Follow Us
Immunotech Biopharm Ltd (HK:6978)
:6978
RESEARCH TOOLSreports
6978 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.50 - HK$6.15
Previous CloseN/A
Volume50.00K
Average Volume (3M)374.37K
Market Cap
HK$1.58B
Enterprise ValueHK$6.67B
Total Cash (Recent Filing)HK$57.49M
Total Debt (Recent Filing)¥116.46M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Aug 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding514,584,000
10 Day Avg. Volume457,300
30 Day Avg. Volume374,366
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)40.93
Price to Sales (P/S)0.00
P/FCF Ratio-59.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Immunotech Biopharm Ltd News
PremiumCompany Announcements
Leadership Changes at Immunotech Biopharm Ltd Amid Governance DisputePremiumCompany Announcements
Immunotech Biopharm Ltd Secures Unanimous Shareholder Support at AGM
PremiumCompany Announcements
Immunotech Biopharm Ltd Announces 2025 AGM and Key Resolutions
PremiumCompany Announcements
Immunotech Biopharm Ltd Announces Board Changes
PremiumCompany Announcements
Immunotech Biopharm Ltd Announces Board and Committee Roles
PremiumCompany Announcements
Immunotech Biopharm’s EAL® Drug Application Accepted by Chinese AuthoritiesPremiumCompany Announcements
Immunotech Biopharm Ltd Postpones Board Meeting to Finalize Annual Results6978 FAQ
What was Immunotech Biopharm Ltd’s price range in the past 12 months?
Immunotech Biopharm Ltd lowest stock price was HK$1.50 and its highest was HK$6.15 in the past 12 months.
What is Immunotech Biopharm Ltd’s market cap?
Immunotech Biopharm Ltd’s market cap is HK$1.58B.
When is Immunotech Biopharm Ltd’s upcoming earnings report date?
Immunotech Biopharm Ltd’s upcoming earnings report date is Aug 22, 2025 which is in 62 days.
How were Immunotech Biopharm Ltd’s earnings last quarter?
Immunotech Biopharm Ltd released its earnings results on Mar 31, 2025. The company reported -HK$0.199 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.199.
Is Immunotech Biopharm Ltd overvalued?
According to Wall Street analysts Immunotech Biopharm Ltd’s price is currently Overvalued.
Does Immunotech Biopharm Ltd pay dividends?
Immunotech Biopharm Ltd does not currently pay dividends.
What is Immunotech Biopharm Ltd’s EPS estimate?
Immunotech Biopharm Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immunotech Biopharm Ltd have?
Immunotech Biopharm Ltd has 514,584,000 shares outstanding.
What happened to Immunotech Biopharm Ltd’s price movement after its last earnings report?
Immunotech Biopharm Ltd reported an EPS of -HK$0.199 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 20.596%.
Which hedge fund is a major shareholder of Immunotech Biopharm Ltd?
Currently, no hedge funds are holding shares in HK:6978
Immunotech Biopharm Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.64%
12-Months-Change
Fundamentals
Return on Equity
-228.99%
Trailing 12-Months
Asset Growth
-35.58%
Trailing 12-Months
Company Description
Immunotech Biopharm Ltd
Immunotech Biopharm Ltd (6978) is a biopharmaceutical company primarily engaged in the research, development, and commercialization of cellular immunotherapy products. The company focuses on creating innovative treatments for cancer, leveraging its expertise in T-cell immunotherapy. Immunotech Biopharm Ltd operates within the biotechnology sector and aims to provide effective therapeutic solutions to improve patient outcomes.
Technical Analysis
Viva Biotech Holdings
―
Shanghai Junshi Biosciences Co., Ltd. Class H
―
Akeso, Inc.
―
Genor Biopharma Holdings Limited
―
Wuxi Biologics (Cayman)
―